Aurion Biotech Employee Directory
Biotechnology ResearchWashington, United States51-200 Employees
Aurion Biotech is a Seattle-based biotechnology company developing advanced cell therapies to address corneal endothelial disease, with the aim of restoring vision. Its candidate, AURN001, is an investigational, single-administration allogeneic therapy for corneal endothelial disease and is among the early clinically validated cell treatments for corneal care. The program is subject to regulatory restrictions that limit use to investigational settings. Based in Seattle, Aurion Biotech operates as a clinical-stage enterprise focused on restoring vision through regenerative cell therapies. In 2026, it announced participation in industry events including the Eye Bank Association of America Annual Meeting, the American-European Congress of Ophthalmic Surgery European Symposium, and the ASGCT conference, reflecting ongoing engagement with the ophthalmology and regenerative medicine communities. In March 2026, the company appointed Dr. Marjan Farid as Chair of its Medical Advisory Board.
1-888-653-2347 
support@leadiq.com 
